Phase II Trial Evaluating the Association of Peripheral Blood Immunologic Response to Therapeutic Response After Adjuvant Treatment with Immune Checkpoint Inhibition (ICI) in Patients with Newly Diagnosed Glioblastoma or Gliosarcoma

In this limited cohort, no detectable difference in the OS was observed between patients with a <i>reactive</i> immune signature and those with a <i>suppressed</i> immune signature.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2025-12-30
DOI
https://doi.org/10.64898/2025.12.23.25342908
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase II Trial Evaluating the Association of Peripheral Blood Immunologic Response to Therapeutic Response After Adjuvant Treatment with Immune Checkpoint Inhibition (ICI) in Patients with Newly Diagnosed Glioblastoma or Gliosarcoma

Kevin Camphausen
medRxiv
Glioma Diagnosis and Treatment
article

Phase II Trial Evaluating the Association of Peripheral Blood Immunologic Response to Therapeutic Response After Adjuvant Treatment with Immune Checkpoint Inhibition (ICI) in Patients with Newly Diagnosed Glioblastoma or Gliosarcoma

Kevin Camphausen
article en

Abstract

In this limited cohort, no detectable difference in the OS was observed between patients with a <i>reactive</i> immune signature and those with a <i>suppressed</i> immune signature.

medRxiv
National Institutes of Health (US)
National Institutes of Health, National Cancer Institute
Openalex Percentile: Top 25%
Glioma Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Phase II Trial Evaluating the Association of Peripheral Blood Immunologic Response to Therapeutic Response After Adjuvant Treatment with Immune Checkpoint Inhibition (ICI) in Patients with Newly Diagnosed Glioblastoma or Gliosarcoma — Kevin Camphausen · medRxiv (2025) | TGRS Research Map | TGRS